000 | 01680 a2200469 4500 | ||
---|---|---|---|
005 | 20250516155729.0 | ||
264 | 0 | _c20131025 | |
008 | 201310s 0 0 eng d | ||
022 | _a1665-2681 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHegade, Vinod S | |
245 | 0 | 0 |
_aPulmonary complications of treatment with pegylated interferon for hepatitis C infection-two case reports. _h[electronic resource] |
260 |
_bAnnals of hepatology _c |
||
300 |
_a629-33 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aCryptogenic Organizing Pneumonia _xchemically induced |
650 | 0 | 4 | _aFatal Outcome |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 |
_aHepatitis, Chronic _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 |
_aLung Diseases, Interstitial _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Organ Failure _xchemically induced |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aRespiratory Distress Syndrome _xchemically induced |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSood, Ruchit | |
700 | 1 | _aSaralaya, Dinesh | |
700 | 1 | _aMoreea, Sulleman | |
773 | 0 |
_tAnnals of hepatology _gvol. 12 _gno. 4 _gp. 629-33 |
|
999 |
_c22878621 _d22878621 |